20(S)-Ginsenoside Rg3 Partially Induces Maturation of HepG2 Cells via the AMPK/HNF4A Pathway.

IF 1.6 4区 医学 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Li Zheng, Yiheng Ding, Xinhao Li, Jingxuan Jia, Yanning Li, Jinsheng Qi
{"title":"20(S)-Ginsenoside Rg3 Partially Induces Maturation of HepG2 Cells via the AMPK/HNF4A Pathway.","authors":"Li Zheng, Yiheng Ding, Xinhao Li, Jingxuan Jia, Yanning Li, Jinsheng Qi","doi":"10.18502/ijph.v54i6.18904","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>We aimed to investigate whether 20(S)-ginsenoside Rg3 (Rg3) reduced heterogeneity by inducing the maturation of HepG2 cells via the AMP-activated protein kinase (AMPK)/hepatocyte nuclear factor 4A (HNF4A) pathway.</p><p><strong>Methods: </strong>This in vitro cell research study was conducted under the guidance of Hebei Medical University, Hebei, China, from Sep 2022 to Dec 2023. HepG2 cells were treated with varying concentrations of Rg3 in a low glucose microenvironment. The mRNA expression of <i>ALBUMIN</i> (<i>ALB</i>, a marker for hepatocyte function) and <i>HNF4A</i> (a marker for differentiation of HCC cell), and AMPK protein levels were measured after significant changes in cell morphology were observed. Additionally, 5-Aminoimidazole-4-carboxamide1-β-D-ribofuranoside (AICAR) (an AMPK agonist) and Compound C (an AMPK inhibitor) were used to explore further the underlying mechanism.</p><p><strong>Results: </strong>Under treatment of 5 μM, 10 μM, and 20 μM Rg3, some cells became flattened and larger, and there was an increase in the mRNA expression of <i>ALB</i> and <i>HNF4A</i> (<i>P</i><0.05). However, there was a decreasing trend in AMPK protein content with 8 μM Rg3 (<i>P</i><0.05). Compared to the control group, some cells exposed to 8 μM Rg3 exhibited pronounced morphological changes, along with upregulated expression of <i>ALB</i> and <i>HNF4A</i> mRNA. However, no such changes were observed when 8 μM Rg3 was combined with 1.6 mM AICAR. Compared to the control group, 10 μM Compound C or 8 μM Rg3 treatments led to similar changes in cell morphology and showed an increasing trend in <i>HNF4A</i> mRNA expression. Additionally, after treatment with Compound C, pHNF4A was mainly in the nucleus, while after Rg3 treatment, it was mostly in the cytoplasm.</p><p><strong>Conclusion: </strong>Rg3 partially induced the maturation of HepG2 cells through the AMPK/HNF4A pathway.</p>","PeriodicalId":49173,"journal":{"name":"Iranian Journal of Public Health","volume":"54 6","pages":"1263-1271"},"PeriodicalIF":1.6000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12241739/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iranian Journal of Public Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18502/ijph.v54i6.18904","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

Background: We aimed to investigate whether 20(S)-ginsenoside Rg3 (Rg3) reduced heterogeneity by inducing the maturation of HepG2 cells via the AMP-activated protein kinase (AMPK)/hepatocyte nuclear factor 4A (HNF4A) pathway.

Methods: This in vitro cell research study was conducted under the guidance of Hebei Medical University, Hebei, China, from Sep 2022 to Dec 2023. HepG2 cells were treated with varying concentrations of Rg3 in a low glucose microenvironment. The mRNA expression of ALBUMIN (ALB, a marker for hepatocyte function) and HNF4A (a marker for differentiation of HCC cell), and AMPK protein levels were measured after significant changes in cell morphology were observed. Additionally, 5-Aminoimidazole-4-carboxamide1-β-D-ribofuranoside (AICAR) (an AMPK agonist) and Compound C (an AMPK inhibitor) were used to explore further the underlying mechanism.

Results: Under treatment of 5 μM, 10 μM, and 20 μM Rg3, some cells became flattened and larger, and there was an increase in the mRNA expression of ALB and HNF4A (P<0.05). However, there was a decreasing trend in AMPK protein content with 8 μM Rg3 (P<0.05). Compared to the control group, some cells exposed to 8 μM Rg3 exhibited pronounced morphological changes, along with upregulated expression of ALB and HNF4A mRNA. However, no such changes were observed when 8 μM Rg3 was combined with 1.6 mM AICAR. Compared to the control group, 10 μM Compound C or 8 μM Rg3 treatments led to similar changes in cell morphology and showed an increasing trend in HNF4A mRNA expression. Additionally, after treatment with Compound C, pHNF4A was mainly in the nucleus, while after Rg3 treatment, it was mostly in the cytoplasm.

Conclusion: Rg3 partially induced the maturation of HepG2 cells through the AMPK/HNF4A pathway.

20(S)-人参皂苷Rg3通过AMPK/HNF4A途径部分诱导HepG2细胞成熟
背景:我们旨在研究20(S)-人参皂苷Rg3 (Rg3)是否通过amp活化蛋白激酶(AMPK)/肝细胞核因子4A (HNF4A)途径诱导HepG2细胞成熟,从而降低异质性。方法:本体外细胞研究于2022年9月至2023年12月在河北医科大学指导下进行。HepG2细胞在低糖微环境中用不同浓度的Rg3处理。观察到细胞形态发生显著变化后,检测白蛋白(ALB,肝细胞功能标志物)、HNF4A (HCC细胞分化标志物)mRNA表达和AMPK蛋白水平。此外,5-氨基咪唑-4-carboxamide1-β- d -核糖呋喃苷(AICAR)(一种AMPK激动剂)和化合物C(一种AMPK抑制剂)被用来进一步探索潜在的机制。结果:在5 μM、10 μM和20 μM Rg3处理下,部分细胞变扁平、变大,ALB和HNF4A mRNA (PPALB和HNF4A mRNA)表达量增加。然而,当8 μM Rg3与1.6 mM AICAR联合使用时,没有观察到这种变化。与对照组相比,10 μM Compound C或8 μM Rg3处理后细胞形态变化相似,HNF4A mRNA表达呈升高趋势。此外,化合物C处理后,pHNF4A主要在细胞核中,而Rg3处理后,pHNF4A主要在细胞质中。结论:Rg3通过AMPK/HNF4A通路部分诱导HepG2细胞成熟。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Iranian Journal of Public Health
Iranian Journal of Public Health PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-
CiteScore
2.20
自引率
7.10%
发文量
300
审稿时长
3-8 weeks
期刊介绍: Iranian Journal of Public Health has been continuously published since 1971, as the only Journal in all health domains, with wide distribution (including WHO in Geneva and Cairo) in two languages (English and Persian). From 2001 issue, the Journal is published only in English language. During the last 41 years more than 2000 scientific research papers, results of health activities, surveys and services, have been published in this Journal. To meet the increasing demand of respected researchers, as of January 2012, the Journal is published monthly. I wish this will assist to promote the level of global knowledge. The main topics that the Journal would welcome are: Bioethics, Disaster and Health, Entomology, Epidemiology, Health and Environment, Health Economics, Health Services, Immunology, Medical Genetics, Mental Health, Microbiology, Nutrition and Food Safety, Occupational Health, Oral Health. We would be very delighted to receive your Original papers, Review Articles, Short communications, Case reports and Scientific Letters to the Editor on the above men­tioned research areas.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信